Posted on November 30th, 2009 by Health News
At RSNA 2009, Sectra launches a new breast imaging PACS workstation built on Sectra RapidConnect™ technology. With this next-generation mammography workstation, Sectra focuses on customer productivity and wide area radiology. In 2003, Sectra was the first vendor to provide a multi-modality workstation tailor-made for high-performance screening. At RSNA 2009, the company introduces an [...]
No Comments »
Filed under: Women's Health
Posted on November 30th, 2009 by Health News
Osteoarthritis (OA), a highly prevalent disease, raised aggregate annual medical care expenditures in the U.S. by $185.5 billion according to researchers from Stony Brook University. Insurers footed $149.4 billion of the total medical spend and out-of-pocket (OOP) expenditures were $36.1 billion (2007 dollars). Results of the cost analysis study are published in the December issue [...]
No Comments »
Filed under: Women's Health
Posted on November 30th, 2009 by Health News
Southern Illinois University researchers determined Medicare beneficiaries living in rural areas were 27% more likely than urban recipients to have total knee or hip replacement surgeries. Researchers found women were more likely than men to undergo total joint replacement surgeries. Differences in elective joint surgeries between white individuals and minorities in both rural and urban [...]
No Comments »
Filed under: Women's Health
Posted on November 29th, 2009 by Health News
The Swedish biotech company Karo Bio (Reuters: KARO.ST) announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration’s lead investigational drug candidate, MK-6913, identified as part of their joint research collaboration. No milestone payment to Karo Bio is associated with the initiation of phase II [...]
No Comments »
Filed under: Women's Health
Posted on November 29th, 2009 by Health News
America’s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 21st anniversary of “World AIDS Day” a global awareness campaign that originated at the 1988 World [...]
No Comments »
Filed under: Pharmacy News
Posted on November 29th, 2009 by Health News
A panel of leading European diabetes experts led by Professor Oliver Schnell from the Diabetes Research Institute in Munich has published a “Consensus Statement A European perspective” (1) on the benefits of self-monitoring of blood glucose values (SMBG). It recommends performing SMBG for all types of diabetes treatment approaches in order to achieve proper glucose [...]
No Comments »
Filed under: Pharmacy News
Posted on November 29th, 2009 by Health News
Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have announced their support of The European Federation of Allergy and Airways Diseases Patients` Associations` (EFA) call for urgent improvement in the care of people with COPD.
No Comments »
Filed under: Pharmacy News
Posted on November 29th, 2009 by Health News
Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective treatment options. Under a licensing agreement with Incyte Corporation, Novartis will have responsibility for the future development of Incyte’s investigational JAK inhibitor outside [...]
No Comments »
Filed under: Pharmacy News
Posted on November 29th, 2009 by Health News
(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate [...]
No Comments »
Filed under: Pharmacy News
Posted on November 29th, 2009 by Health News
Effient(R) (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention (PCI) and a second one for patients with ST elevation myocardial infarction (STEMI), or severe heart attack.
No Comments »
Filed under: Pharmacy News
